Basics Tevogen Bio Holdings Inc. Common Stock IPO Date: February 15, 2024 Sector: Healthcare Industry: Biotech Market Cap: $237.22M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 6.48% Avg Daily Range (30 D): $0.04 | 3.60% Avg Daily Range (90 D): $0.05 | 3.78% Institutional Daily Volume Avg Daily Volume: 3.41M Avg Daily Volume (30 D): 1.17M Avg Daily Volume (90 D): .84M Trade Size Avg Trade Size (Sh.): 365 Avg Trade Size (Sh.) (30 D): 343 Avg Trade Size (Sh.) (90 D): 323 Institutional Trades Total Inst.Trades: 3 Avg Inst. Trade: $.78M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $.98M Avg Inst. Trade Volume: .65M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.75M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 1.04M     News May 5, 2025 @ 4:35 PM AI Healthcare Boom Gains Speed as Regulators and I... Source: Prnewswire Apr 30, 2025 @ 7:49 PM CD8 Technology Signs Letter of Intent for Tevogen ... Source: N/A Apr 25, 2025 @ 6:33 PM Tevogen Bio Announces 2025 Annual Meeting Source: N/A Apr 17, 2025 @ 6:54 PM Tevogen Bio Finalizes Agreement for Company's Own ... Source: Globe Newswire Apr 17, 2025 @ 6:54 PM Tevogen Bio Finalizes Agreement for Companyâ€â„... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.07 $-.06 $-.07 Diluted EPS $-.07 $-.06 $-.07 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -10.37M $ -9.44M $ -13.73M Operating Income / Loss $ -10.36M $ -9.36M $ -53.56M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio